In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.
All Keywords
【저자키워드】 COVID-19, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, SARS-CoV-2, HIV/AIDS, Vaccines, Inactivated vaccine, Hong Kong, zoonoses., persons living with HIV,
【저자키워드】 COVID-19, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, SARS-CoV-2, HIV/AIDS, Vaccines, Inactivated vaccine, Hong Kong, zoonoses., persons living with HIV,